Révital Rattenbach

652 total citations
13 papers, 449 citations indexed

About

Révital Rattenbach is a scholar working on Pharmacology, Rheumatology and Molecular Biology. According to data from OpenAlex, Révital Rattenbach has authored 13 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 7 papers in Rheumatology and 3 papers in Molecular Biology. Recurrent topics in Révital Rattenbach's work include Inflammatory mediators and NSAID effects (7 papers), Osteoarthritis Treatment and Mechanisms (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Révital Rattenbach is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Osteoarthritis Treatment and Mechanisms (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Révital Rattenbach collaborates with scholars based in France, United States and Israel. Révital Rattenbach's co-authors include Frédéric Relaix, Francis Bérenbaum, Einat Blitz, C. Jacques, Pascal Maire, Dario Breitel, Ryan B. Rountree, Sharon Krief, Yulia Shwartz and Elazar Zelzer and has published in prestigious journals such as The Journal of Comparative Neurology, Scientific Reports and Developmental Cell.

In The Last Decade

Révital Rattenbach

11 papers receiving 445 citations

Peers

Révital Rattenbach

RHEUM

GENET

SURGE

PHARM

Tomoya Uchimura Japan

Alfred Li United States

E Torchiana Italy

Melanie Fisher United States

Lisa L. Abler United States

T Arnett United Kingdom

Fatih Bayraklı Türkiye

Eveliina Jakkula Finland

Joanna Smeeton United States

Alvise Schiavinato Italy

Tomoya Uchimura Japan

Révital Rattenbach

166 ×0.9

107 ×1.2

RHEUM

67 ×0.8

GENET

47 ×0.6

SURGE

27 ×0.5

PHARM

Citations per year, relative to Révital Rattenbach Révital Rattenbach (= 1×) peers Tomoya Uchimura

Countries citing papers authored by Révital Rattenbach

Since Specialization

Citations

This map shows the geographic impact of Révital Rattenbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Révital Rattenbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Révital Rattenbach more than expected).

Fields of papers citing papers by Révital Rattenbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Révital Rattenbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Révital Rattenbach. The network helps show where Révital Rattenbach may publish in the future.

Co-authorship network of co-authors of Révital Rattenbach

This figure shows the co-authorship network connecting the top 25 collaborators of Révital Rattenbach. A scholar is included among the top collaborators of Révital Rattenbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Révital Rattenbach. Révital Rattenbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Rattenbach, Révital, et al.. (2025). Intra-Articular Administration of Liraglutide for Cartilage Regeneration in Osteoarthritis: In Vitro and In Vivo Evidence of Prochondrogenic Potential. Osteoarthritis and Cartilage. 33. S366–S367.

Babault, Nicolas, Céline Martin, Bénédicte Desforges, et al.. (2025). TDP-43 nuclear retention is antagonized by hypo-phosphorylation of its C-terminus in the cytoplasm. Communications Biology. 8(1). 136–136.

Bismuth, Keren, et al.. (2024). Intra-articular Administration of Liraglutide Mitigates Synovial Tissue Alteration and Cartilage Degradation in Preclinical Osteoarthritis Models. Osteoarthritis and Cartilage. 32. S385–S386. 1 indexed citations

Jacques, C., L. Sudre, John Breton, et al.. (2022). Targeting the GLP-1/GLP-1R axis to treat osteoarthritis: A new opportunity?. Journal of Orthopaedic Translation. 32. 121–129. 47 indexed citations

Sudre, L., John Breton, Carole Bougault, et al.. (2022). Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis. Scientific Reports. 12(1). 1567–1567. 78 indexed citations

Bérenbaum, Francis, L. Sudre, Keren Bismuth, et al.. (2021). POS0373 LIRAGLUTIDE HAS POTENT ANTI-INFLAMMATORY AND ANTI-CATABOLIC IN VITRO ACTIVITIES IN OSTEOARTHRITIS. Annals of the Rheumatic Diseases. 80. 417–417. 2 indexed citations

Bérenbaum, Francis, et al.. (2020). Protective effects of intra-articular formulated liraglutide in osteoarthritis : preclinical studies. Osteoarthritis and Cartilage. 28. S486–S486. 4 indexed citations

Bérenbaum, Francis, John Breton, L. Sudre, et al.. (2020). THU0055 ANTI-DEGRADATIVE AND PRO-CHONDROGENIC PROPERTIES OF LIRAGLUTIDE, A GLUCAGON-LIKE-PEPTIDE 1 RECEPTOR AGONIST: EVIDENCE FROM PRECLINICAL STUDIES AND IMPLICATION FOR OSTEOARTHRITIS. Annals of the Rheumatic Diseases. 79. 239–239. 3 indexed citations

Dhainaut, Jean-François, Olivier Blin, Pascal Bilbault, et al.. (2019). Health research and innovation: Can we optimize the interface between startups/pharmaceutical companies and academic health care institutions or not?. Therapies. 75(1). 113–123. 7 indexed citations

10.

Zalc, Antoine, Révital Rattenbach, Frédéric Aurade, Bruno Cadot, & Frédéric Relaix. (2015). Pax3 and Pax7 Play Essential Safeguard Functions against Environmental Stress-Induced Birth Defects. Developmental Cell. 33(1). 56–66. 41 indexed citations

11.

Ho, Andrew Tri Van, Shinichiro Hayashi, Dominique Bröhl, et al.. (2011). Neural Crest Cell Lineage Restricts Skeletal Muscle Progenitor Cell Differentiation through Neuregulin1-ErbB3 Signaling. Developmental Cell. 21(2). 273–287. 42 indexed citations

12.

Mouton‐Liger, François, Sophie Thomas, Révital Rattenbach, et al.. (2011). PCP4 (PEP19) overexpression induces premature neuronal differentiation associated with Ca²⁺/Calmodulin‐Dependent kinase II‐δ activation in mouse models of down syndrome. The Journal of Comparative Neurology. 519(14). 2779–2802. 33 indexed citations

13.

Kahn, Joy, Yulia Shwartz, Einat Blitz, et al.. (2009). Muscle Contraction Is Necessary to Maintain Joint Progenitor Cell Fate. Developmental Cell. 16(5). 734–743. 191 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact